Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Corticosteroid therapy for nephrotic syndrome].

Yoshia Tanaka1

  • 1First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 27, 2004
PubMed
Summary

Primary nephrotic syndrome involves immune T cell dysfunction causing kidney damage. Corticosteroids are a common treatment, but steroid resistance necessitates other therapies and careful management of side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019

Area of Science:

  • Immunology
  • Nephrology
  • Pathophysiology

Context:

  • Primary nephrotic syndrome etiology is largely unknown.
  • Immune T cell disorders are implicated in glomerular dysfunction.
  • Corticosteroids are the initial treatment for nephrotic syndrome.

Purpose:

  • To review the role of immune T cell disorders in nephrotic syndrome.
  • To discuss corticosteroid treatment, steroid resistance, and alternative therapies.
  • To highlight the adverse effects of corticosteroid therapy and the need for management.

Summary:

  • Nephrotic syndrome is linked to immune T cell dysfunction and glomerular damage.
  • Steroid responsiveness is a key prognostic factor; resistance requires immunosuppressants or methylprednisolone pulse therapy.
  • Corticosteroid treatment, while beneficial, carries significant risks like infections and bone issues, necessitating vigilant monitoring and intervention.

Impact:

  • Provides insights into the immunologic basis of nephrotic syndrome.
  • Clarifies treatment strategies based on steroid responsiveness.
  • Emphasizes the critical need for managing corticosteroid-related adverse events in nephrotic syndrome patients.

Related Experiment Videos